Patent directory · USPTO A61K / A61P
Patents matching “BIOMARIN PHARMACEUTICAL INC.”
112 pharma patents match "BIOMARIN PHARMACEUTICAL INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 112 pharmaceutical patents matching "BIOMARIN PHARMACEUTICAL INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10758598
TPP-1 formulations and methods for treating CLN2 disease
granted -
US 10683530
Detection of oligosaccharides
granted -
US 10646550
Use of C-type natriuretic peptide variants to treat skeletal dysplasia
granted -
US 10563183
Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
granted -
US 10526346
Histone deacetylase inhibitors
granted -
US 10512675
Adeno-associated virus factor VIII vectors, associated viral particles and therapeutic formulations comprising the same
granted -
US 10463718
Adeno-associated virus factor VIII vectors
granted -
US 10428028
HDAC inhibitors
granted -
US 10308608
Histone deacetylase inhibitors
granted -
US 10301323
Histone deacetylase inhibitors
granted -
US 10300113
Targeted therapeutic proteins
granted -
US 10301369
Nucleic acids encoding targeted therapeutic lysosomal enzyme fusion proteins
granted -
US 10279015
TPP-1 formulations and methods for treating CLN2 disease
granted -
US 10239832
N-(1-hydroxy-3-(pyrrolidinyl)propan-2-yl)pyrrolidine-3-carboxamide derivatives as glucosylceramide synthase inhibitors
granted -
US 10227323
Glucosylceramide synthase inhibitors for the treatment of diseases
granted -
US 10227312
Glucosylceramide synthase inhibitors for the treatment of diseases
granted -
US 10221408
Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof
granted -
US 10029988
HDAC inhibitors
granted -
US 9993481
Methods and compositions for the treatment of metabolic disorders
granted -
US 9908899
Histone deacetylase inhibitors
granted -
US 9907834
Use of C-type natriuretic peptide variants to treat skeletal dysplasia
granted -
US 9873867
Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
granted -
US 9845346
Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
granted -
US 9834587
Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
granted